
Antidepressants and Cognitive Decline in Dementia: What Caregivers Need to Know
If you are caring for someone with dementia and wondering whether antidepressants might be making their thinking worse, you are not alone. Recent research from Sweden suggests that certain antidepressants, especially when used at higher doses, may be linked to faster cognitive decline and a higher risk of severe dementia. This does not mean that antidepressants are always harmful, but it does mean that careful monitoring and open communication with the healthcare team are essential. The good news is that there are concrete steps you can take to observe changes, ask the right questions, and help ensure that any medication used is truly helping, not harming.
Key points
- Antidepressant use in dementia has been linked to faster cognitive decline in recent Swedish research, especially at higher doses of SSRIs.
- This does not mean all antidepressants are harmful; the benefits for mood and quality of life may outweigh risks for some individuals.
- Always monitor for sudden changes in cognition, which may signal a medication side effect or another medical issue like infection.
- Work with the doctor to review the medication's anticholinergic burden and consider lower doses or alternatives.
- Non-drug approaches like pleasant activities, exercise, and social engagement can improve mood without cognitive risks.
- Never stop an antidepressant suddenly; always taper under medical supervision to avoid withdrawal and worsening symptoms.
What the Research Shows
A large Swedish national study published in 2025 tracked people with dementia who were new users of antidepressants. The researchers found that those currently taking antidepressants experienced faster cognitive decline compared to those not taking them. Moreover, higher doses of a common class of antidepressants called SSRIs (selective serotonin reuptake inhibitors) were linked to a greater risk of developing severe dementia, fractures, and even death. This does not prove that antidepressants cause these outcomes, but it does highlight a strong association that warrants careful attention.
Why This Might Happen
There are several possible reasons why antidepressants could be linked to faster cognitive decline in dementia. Some antidepressants have anticholinergic effects, meaning they block a brain chemical called acetylcholine, which is important for memory and thinking. The NICE guidelines specifically warn that medicines with high anticholinergic burden can worsen cognitive impairment. Additionally, depression itself can mimic or worsen dementia symptoms, so treating depression might sometimes unmask the underlying dementia progression. It is also possible that people with more severe dementia are more likely to be prescribed antidepressants, creating a statistical link that is not actually causal.
The Importance of Context
It is crucial to remember that untreated depression in dementia can also cause significant suffering, including loss of interest, withdrawal, and even physical decline. For many people, antidepressants improve mood, sleep, and appetite, which can indirectly support cognitive function. The key is to weigh the potential risks against the benefits for each individual. A sudden decline in cognition should always be investigated for other causes, such as infection, medication side effects, or delirium, before attributing it solely to an antidepressant.
General caregiving information, not medical advice. Check medications and major care changes with your clinician.
Step-by-step
Keep a daily log of specific cognitive and mood changes (e.g., 'forgot how to use the TV remote') that occur within days or weeks of starting or adjusting an antidepressant.
Request a medication review with the prescriber; ask about anticholinergic burden, whether the dose is appropriate, and if a different class (SNRI, mirtazapine) might be safer.
After 4–6 weeks on a stable dose, evaluate if the antidepressant is clearly improving mood, appetite, or agitation. If no benefit, discuss tapering or switching.
Taper the antidepressant slowly under medical supervision over weeks or months to avoid withdrawal symptoms like anxiety, confusion, and physical distress.
What not to do
Do not stop the antidepressant suddenly, as withdrawal can cause worsening anxiety, confusion, and potentially life-threatening complications.
Do not assume worsening confusion is only from the antidepressant; depression itself causes cognitive decline, and untreated depression can worsen dementia.
Do not ignore sudden confusion, drowsiness, or unsteadiness, which may signal delirium from infection or medication and requires urgent attention.
Do not assume all antidepressants are the same; for example, paroxetine (high anticholinergic) is generally avoided in older adults.
Do not overlook non-drug approaches (e.g., behavioral activation, gentle exercise, social engagement) for mild-to-moderate depression, as they lack cognitive side effects.
Practical tools
Daily Log Template
A table with columns for Date, Mood (1–10), Specific Cognitive Change (e.g., 'forgot the remote'), New Symptoms (drowsiness, falls), and Notes. Use to detect patterns and inform the doctor.
Doctor Visit Prep Kit
A checklist and script: list all meds (including OTC). Open with, 'I’m concerned the antidepressant may worsen cognition; can we review the dose or try an option with fewer cognitive side effects?' and 'What is the anticholinergic burden, and are there alternatives?'
Non-Drug Mood Support Plan
A list of one daily activity the person once enjoyed (music, photos, walks, crafts). Use to test if mood lifts without medication, and report results to the doctor.
How much does physical function decline over six months in advanced dementia?
The guide focuses on antidepressants and cognitive decline in dementia, not on physical function in advanced dementia, so I cannot provide a specific six-month decline rate. For your loved one's physical changes, I recommend speaking with their doctor, who can give you a personalized outlook based on their unique condition.
Can common medications for blood pressure, cholesterol, and diabetes help slow cognitive decline?
The guide does not address medications for blood pressure, cholesterol, or diabetes; it focuses on antidepressants. However, managing these conditions is vital for overall health, so please ask their doctor how these treatments may support your loved one's brain and body.
Discuss with your clinician
Ask the doctor: 'What is the anticholinergic burden of this antidepressant, and is there a safer alternative?'
Ask: 'Is the current dose the lowest effective dose? Could we try a lower dose or a different class of antidepressant?'
If the person is on an SSRI, ask: 'Is this particular SSRI associated with higher risk of cognitive decline in dementia? Should we consider switching to an SNRI or mirtazapine?'
Ask: 'What signs should I watch for that would indicate the medication is causing harm, and when should I call you?'
If the person has Lewy body dementia, ask: 'Is this antidepressant safe for someone with Lewy body dementia, given the high sensitivity to medications?'
Ask: 'Can we try non-drug approaches for depression first, such as behavioral activation or exercise, before starting or changing medication?'
Related guides
- Public health burden of cognitive decline
- Family-delivered life review for depression in dementia
- Your Step-by-Step Guide to a Complete Medication Review for Your Loved One with Dementia
- Executive functioning decline in dementia
- SSRI Dose-Response Risks in Dementia: What Caregivers Need to Know
- Why Antipsychotics Are Dangerous in Lewy Body Dementia: A Guide for Caregivers
- Maintaining human-to-human connection through non-care moments
- Caregiver advocacy in Australia
- sundowning versus delirium
- Deprescribing Unnecessary Medications: A Step-by-Step Guide for Dementia Caregivers
- Cognitive Enhancers and Test Scores: What Caregivers Need to Know for Mild to Moderate Alzheimer's
- When an Antidepressant Stops Working: Understanding Tolerance and What to Do
- Antithrombotic Therapy for Cognitive Decline in Cerebral Small Vessel Disease: A Caregiver’s Guide